Latest California Healthline Stories
California Voters Will Have Their Say On Drug Prices
Heated battle expected over November ballot proposal to curb state’s prescription drug costs, as pharmaceutical industry opens its pocketbook to defeat the measure.
Debating The New Ballot Measure To Control Prescription Drug Prices
The California Drug Price Relief Act would mandate that the state pay no more for prescription drugs than the U.S. Department of Veterans Affairs. David Gorn sat down with Rand Martin, Sacramento lobbyist for the AIDS Healthcare Foundation, which is sponsoring the ballot measure, and Kathy Fairbanks, campaign consultant for the committee opposing it.
Unreasonable Rate Hike? Proposed Legislation Would Tell You About It
A new Senate bill proposes that the state inform consumers when state officials find health insurance rates to be unjustified.
A Closer Look At The Senate’s Investigation Of Tainted Medical Scopes
A Senate investigation recently found that 16 hospitals around the U.S. failed to file mandatory paperwork with the federal government after patients at their hospitals became infected or died from the use of tainted medical scopes. KHN’s Chad Terhune, who reported on the story for the Los Angeles Times, spoke with Madeline Brand on KCRW’s Press Play about the investigation and steps the scope maker is taking to stop the infections.
Want Into A Clinical Trial? Read This First.
Experimental drugs might help desperate patients, but don’t count on an easy cure.
MCO Tax a Looming Question in Governor’s Upcoming Budget Proposal
If calling a special legislative session didn’t work, what’s next on Gov. Brown’s agenda to replace the loss of the $1 billion managed care organization tax?
Heavy Use Of CT Scans Raises Concerns About Patients’ Exposure To Radiation
CT scans, which are administered more than 85 million times a year, are an important diagnostic tool, but just one can be equivalent to 200 X-rays. Some doctors warn that health providers are not considering possible consequences when ordering the tests.
Expensive Drugs in 2016 Crosshairs
Lawmakers, policymakers and California voters are poised this year to move past dismay and discussion about rising prescription drug prices. With a new law on the books in California and a petition approved for the statewide ballot, dismay may give way to action.
Health Reform in 2015: A Year in Review
From the King v. Burwell decision to the ultimate “doc fix,” there were some major developments in health care reform this year.
Can Drug Companies Survive Their Martin Shkreli Moment?
The pharmaceutical industry has been under scrutiny for the past month, after one executive’s decision to hike the price of a drug by more than 5,000% overnight attracted the attention of presidential candidates.